Skip to main content

Advertisement

Table 1 Patient disposition by treatment group.

From: Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study

  Abrupt Gradual 1 Gradual 2 All treatments
Randomized, n 41 40 42 123
Safety population, n 40 39 42 121
Completed, % 75 72 88 79
Discontinued, % 25 28 12 21
   Adverse event 5 15 5 8
   Withdrew consent 10 8 0 6
   Insufficient response 5 0 0 2
   Lost to follow-up 0 3 2 2
   Noncompliance 0 0 2 1
   Other 5 3 2 2
  1. The safety population includes all randomized patients who received at least one dose of study medication. Between-group discontinuation differences were not significant (p = 0.1635).